Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

Advanced glycation end products (AGEs) are compounds formed after the non-enzymatic addition of reducing sugars to lipids, proteins, and nucleic acids. They are associated with the development of various clinical complications observed in diabetes and cardiovascular diseases, such as retinopathy, ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Koerich, Suélyn, Parreira, Gabriela Machado, de Almeida, Douglas Lamounier, Vieira, Rafael Pinto, de Oliveira, Antônio Carlos Pinheiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Neurology, Pharmacology, Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190138/
https://www.ncbi.nlm.nih.gov/pubmed/36154605
http://dx.doi.org/10.2174/1570159X20666220922153903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190138/
https://www.ncbi.nlm.nih.gov/pubmed/36154605
http://dx.doi.org/10.2174/1570159X20666220922153903

Ejemplares similares